LeMaitre Vascular, Inc.
LMAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,983 | $1,878 | $1,894 | $2,074 |
| - Cash | $25 | $27 | $25 | $26 |
| + Debt | $186 | $186 | $185 | $186 |
| Enterprise Value | $2,143 | $2,037 | $2,054 | $2,234 |
| Revenue | $61 | $64 | $60 | $56 |
| % Growth | -5% | 7.3% | 7.5% | – |
| Gross Profit | $46 | $45 | $41 | $39 |
| % Margin | 75.3% | 70% | 69.2% | 69.3% |
| EBITDA | $26 | $22 | $18 | $20 |
| % Margin | 43.4% | 34.3% | 30.2% | 36.2% |
| Net Income | $17 | $14 | $11 | $11 |
| % Margin | 28.4% | 21.5% | 18.4% | 20.1% |
| EPS Diluted | 0.75 | 0.6 | 0.48 | 0.49 |
| % Growth | 25% | 25% | -2% | – |
| Operating Cash Flow | $29 | $20 | $9 | $15 |
| Capital Expenditures | -$2 | -$1 | -$1 | -$2 |
| Free Cash Flow | $26 | $19 | $8 | $13 |